630 related articles for article (PubMed ID: 19859541)
1. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ
PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
[TBL] [Abstract][Full Text] [Related]
2. Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.
Chaichana P; Okabayashi T; Puiprom O; Sasayama M; Sasaki T; Yamashita A; Ramasoota P; Kurosu T; Ikuta K
PLoS One; 2014; 9(3):e92173. PubMed ID: 24642752
[TBL] [Abstract][Full Text] [Related]
3. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.
Andrade DV; Katzelnick LC; Widman DG; Balmaseda A; de Silva AM; Baric RS; Harris E
mBio; 2017 Sep; 8(5):. PubMed ID: 28928210
[TBL] [Abstract][Full Text] [Related]
5. Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants.
Adimy M; Mancera PFA; Rodrigues DS; Santos FLP; Ferreira CP
Bull Math Biol; 2020 Jan; 82(2):24. PubMed ID: 31993759
[TBL] [Abstract][Full Text] [Related]
6. Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.
Wang M; Yang F; Huang D; Huang Y; Zhang X; Wang C; Zhang S; Zhang R
Front Cell Infect Microbiol; 2017; 7():157. PubMed ID: 28536674
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():597. PubMed ID: 29740424
[TBL] [Abstract][Full Text] [Related]
8. The human antibody response to dengue virus infection.
Wahala WM; Silva AM
Viruses; 2011 Dec; 3(12):2374-95. PubMed ID: 22355444
[TBL] [Abstract][Full Text] [Related]
9. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.
de Alwis R; Williams KL; Schmid MA; Lai CY; Patel B; Smith SA; Crowe JE; Wang WK; Harris E; de Silva AM
PLoS Pathog; 2014 Oct; 10(10):e1004386. PubMed ID: 25275316
[TBL] [Abstract][Full Text] [Related]
10. Anti-dengue virus envelope protein domain III IgG ELISA among infants with primary dengue virus infections.
Libraty DH; Zhang L; Obcena A; Brion JD; Capeding RZ
Acta Trop; 2015 Feb; 142():103-7. PubMed ID: 25460346
[TBL] [Abstract][Full Text] [Related]
11. Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cells.
Moi ML; Takasaki T; Saijo M; Kurane I
Arch Virol; 2014 Jan; 159(1):103-16. PubMed ID: 23900750
[TBL] [Abstract][Full Text] [Related]
12. Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.
Fink AL; Williams KL; Harris E; Alvine TD; Henderson T; Schiltz J; Nilles ML; Bradley DS
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005721. PubMed ID: 28686617
[TBL] [Abstract][Full Text] [Related]
13. Inapparent primary dengue virus infections reveal hidden serotype-specific epidemiological patterns and spectrum of infection outcome: a cohort study in Nicaragua.
Bos S; Zambrana JV; Duarte E; Graber AL; Huffaker J; Montenegro C; Premkumar L; Gordon A; Balmaseda A; Harris E
medRxiv; 2024 Apr; ():. PubMed ID: 38633800
[TBL] [Abstract][Full Text] [Related]
14. The incidence, characteristics, and presentation of dengue virus infections during infancy.
Capeding RZ; Brion JD; Caponpon MM; Gibbons RV; Jarman RG; Yoon IK; Libraty DH
Am J Trop Med Hyg; 2010 Feb; 82(2):330-6. PubMed ID: 20134013
[TBL] [Abstract][Full Text] [Related]
15. Progress towards understanding the pathogenesis of dengue hemorrhagic fever.
Pang X; Zhang R; Cheng G
Virol Sin; 2017 Feb; 32(1):16-22. PubMed ID: 27853992
[TBL] [Abstract][Full Text] [Related]
16. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679
[TBL] [Abstract][Full Text] [Related]
17. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
[TBL] [Abstract][Full Text] [Related]
18. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
[TBL] [Abstract][Full Text] [Related]
19. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
Lau L; Green AM; Balmaseda A; Harris E
J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year.
Montoya M; Gresh L; Mercado JC; Williams KL; Vargas MJ; Gutierrez G; Kuan G; Gordon A; Balmaseda A; Harris E
PLoS Negl Trop Dis; 2013; 7(8):e2357. PubMed ID: 23951377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
